A more complete and accurate clinical spectrum can now be drawn for Nav1.4 channelopathies with a full continuum of myofiber excitability ranging from hyperexcitability in SCM due to GoF changes to unexcitable myofibers in SCW due to LoF changes (Figure 5). This evidence concerns the gene SCN4A and channelopathy.